跳至主要内容
临床试验/DRKS00029691
DRKS00029691招募中未知

Reduction of the risk of dialysis - MinDial

KfH-Stiftung Präventivmedizin,0 个研究点目标入组 357 人开始时间: 2022年9月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
357

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Health insurance with KNAPPSCHAFT
  • - Admission to one of the participating hospitals from 20 September 2022
  • - Existing chronic renal insufficiency (either already known and documented in the KIS by diagnoses such as N17.99 or N18.1-.9, N19, R31, R80) or detected during hospitalization (<60 ml/min/1.73 m² according to CKD-Epi, as opposed to acute renal failure)
  • - Risk of end-stage renal failure within 5 years according to the KFRE score of at least 15% (date of laboratory determination before 20.06.2023) or at least 9% (from 20.06.2023)
  • - Consent to be contacted after dismissal and to contact the HA/HÄ and the FA/FA

排除标准

  • - Patients with = 2 consultations with a nephrological specialist in the last 12 months before enrollment
  • - Included in MinDial during previous hospital stay
  • - Pregnancy

研究者

发起方
KfH-Stiftung Präventivmedizin,

相似试验

Reduction of the risk of dialysis | 临床试验